Laboratorios Richmond SACIF

Laboratorios Richmond SACIF EBIT Margin

The EBIT Margin (Operating Margin) of Laboratorios Richmond SACIF (RICH.BA) as of Nov 22, 2026 is 16.96 %. In the previous year, EBIT Margin (Operating Margin) was 13.61 % — a change of 24.63% (higher).

EBIT Margin

16.96 %

YoY

24.63%

Last updated:

EBIT Margin (Operating Margin) of Laboratorios Richmond SACIF is 2024 16.96 % . EBIT Margin (Operating Margin) of Laboratorios Richmond SACIF was 2023 13.61 % . It decreases by 24.63% higher compared to the previous year.

For Laboratorios Richmond SACIF, the operating (EBIT) margin of 17.0% is down versus 25.0% a few years ago.

The Laboratorios Richmond SACIF EBIT Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Margin
Date
EBIT Margin
Jan 1, 2017
12.34 ARS
Jan 1, 2018
6.18 ARS
Jan 1, 2019
20.04 ARS
Jan 1, 2020
24.96 ARS
Jan 1, 2021
13.88 ARS
Jan 1, 2022
16.09 ARS
Jan 1, 2023
13.61 ARS
Jan 1, 2024
16.96 ARS
The Laboratorios Richmond SACIF EBIT Margin history
YEAREBIT MarginYoY
16.96 %+24.63%
13.61 %-15.41%
16.09 %+15.90%
13.88 %-44.39%
24.96 %+24.52%
20.04 %+224.13%
6.18 %-49.88%
12.34 %-56.09%
28.10 %+27.19%
22.09 %+30.61%
16.91 %+17,126.06%
0.10 %-20.35%
0.12 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Laboratorios Richmond SACIF Stock analysis

What does Laboratorios Richmond SACIF do? Laboratorios Richmond SACIF is a specialized pharmaceutical company focused on the manufacturing and marketing of medications. It was founded in 1935 and is headquartered in Buenos Aires, Argentina. The company has extensive experience in the development of medications and biological products, with expertise in pharmaceutical research and development. It has various business divisions including generics, biological medications, vaccines, oncology medications, and medical devices. The company's products range from simple painkillers and antihistamines to important medications for treating cancer and HIV. Richmond SACIF also manufactures vaccines against diseases such as Hepatitis A and B, polio, influenza, tetanus, and other infectious diseases. Additionally, the company produces a wide range of medications for treating different types of cancer and offers medical instruments and surgical devices. Its business model focuses on innovation and meeting the needs of patients, investing in research and development to develop new and innovative products. The company also has strict quality control measures to ensure the highest pharmaceutical standards. With its rich history and broad range of products, Laboratorios Richmond SACIF is a key player in the global pharmaceutical market and will continue to play an important role in improving the health of people worldwide. Laboratorios Richmond SACIF is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Laboratorios Richmond SACIF stock

EBIT Margin (Operating Margin) of Laboratorios Richmond SACIF is 16.96 % in 2024.

EBIT Margin (Operating Margin) of Laboratorios Richmond SACIF changed from 13.61 % to 16.96 %, representing a 24.63% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) Laboratorios Richmond SACIF since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s Laboratorios Richmond SACIF with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Laboratorios Richmond SACIF

All Key Metrics — Laboratorios Richmond SACIF